Annual CFI
-$622.00 K
+$859.00 K+58.00%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual cash flow from investing activities is -$622.00 thousand, with the most recent change of +$859.00 thousand (+58.00%) on December 31, 2022.
- During the last 3 years, EVLO annual CFI has fallen by -$52.59 million (-101.20%).
- EVLO annual CFI is now -101.20% below its all-time high of $51.97 million, reached on December 31, 2019.
Performance
EVLO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$513.00 K
+$513.00 K+100.00%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly cash flow from investing activities is $513.00 thousand, with the most recent change of +$513.00 thousand (+100.00%) on September 30, 2023.
- Over the past year, EVLO quarterly CFI has increased by +$522.00 thousand (+5800.00%).
- EVLO quarterly CFI is now -98.30% below its all-time high of $30.12 million, reached on March 31, 2019.
Performance
EVLO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$273.00 K
+$522.00 K+209.64%
September 30, 2023
Summary
- As of February 8, 2025, EVLO TTM cash flow from investing activities is $273.00 thousand, with the most recent change of +$522.00 thousand (+209.64%) on September 30, 2023.
- Over the past year, EVLO TTM CFI has increased by +$192.00 thousand (+237.04%).
- EVLO TTM CFI is now -99.66% below its all-time high of $81.01 million, reached on September 30, 2019.
Performance
EVLO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
EVLO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +58.0% | +5800.0% | +237.0% |
| 3 y3 years | -101.2% | +296.6% | +119.9% |
| 5 y5 years | +64.3% | +100.6% | -99.5% |
EVLO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +58.0% | at high | +321.1% | at high | +118.4% |
| 5 y | 5-year | -101.2% | +58.0% | at high | +161.6% | -99.5% | +111.5% |
| alltime | all time | -101.2% | +99.0% | -98.3% | +100.6% | -99.7% | +100.3% |
Evelo Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $513.00 K(>+9900.0%) | $273.00 K(-209.6%) |
| Jun 2023 | - | $0.00(-100.0%) | -$249.00 K(-48.2%) |
| Mar 2023 | - | -$12.00 K(-94.7%) | -$481.00 K(-22.7%) |
| Dec 2022 | -$622.00 K(-58.0%) | -$228.00 K(+2433.3%) | -$622.00 K(-867.9%) |
| Sep 2022 | - | -$9000.00(-96.1%) | $81.00 K(-111.3%) |
| Jun 2022 | - | -$232.00 K(+51.6%) | -$719.00 K(-45.5%) |
| Mar 2022 | - | -$153.00 K(-132.2%) | -$1.32 M(-10.9%) |
| Dec 2021 | -$1.48 M(+12.6%) | $475.00 K(-158.7%) | -$1.48 M(-37.4%) |
| Sep 2021 | - | -$809.00 K(-2.9%) | -$2.37 M(+30.2%) |
| Jun 2021 | - | -$833.00 K(+165.3%) | -$1.82 M(+51.4%) |
| Mar 2021 | - | -$314.00 K(-23.2%) | -$1.20 M(-8.7%) |
| Dec 2020 | -$1.31 M | -$409.00 K(+56.7%) | -$1.31 M(-3.9%) |
| Sep 2020 | - | -$261.00 K(+20.8%) | -$1.37 M(-175.8%) |
| Jun 2020 | - | -$216.00 K(-49.7%) | $1.80 M(-91.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$429.00 K(-7.3%) | $21.42 M(-58.8%) |
| Dec 2019 | $51.97 M(-186.4%) | -$463.00 K(-115.9%) | $51.97 M(-35.9%) |
| Sep 2019 | - | $2.91 M(-85.0%) | $81.01 M(-1119.7%) |
| Jun 2019 | - | $19.40 M(-35.6%) | -$7.95 M(-72.6%) |
| Mar 2019 | - | $30.12 M(+5.4%) | -$29.00 M(-51.8%) |
| Dec 2018 | -$60.13 M(+3351.7%) | $28.58 M(-133.2%) | -$60.13 M(-32.3%) |
| Sep 2018 | - | -$86.05 M(+5074.1%) | -$88.83 M(+2508.0%) |
| Jun 2018 | - | -$1.66 M(+66.3%) | -$3.41 M(+31.5%) |
| Mar 2018 | - | -$1.00 M(+726.4%) | -$2.59 M(+48.7%) |
| Dec 2017 | -$1.74 M(-118.8%) | -$121.00 K(-80.5%) | -$1.74 M(+7.5%) |
| Sep 2017 | - | -$622.00 K(-26.7%) | -$1.62 M(+62.3%) |
| Jun 2017 | - | -$848.00 K(+461.6%) | -$999.00 K(+561.6%) |
| Mar 2017 | - | -$151.00 K | -$151.00 K |
| Dec 2016 | $9.26 M | - | - |
FAQ
- What is Evelo Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for Evelo Biosciences?
- What is Evelo Biosciences annual CFI year-on-year change?
- What is Evelo Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Evelo Biosciences?
- What is Evelo Biosciences quarterly CFI year-on-year change?
- What is Evelo Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for Evelo Biosciences?
- What is Evelo Biosciences TTM CFI year-on-year change?
What is Evelo Biosciences annual cash flow from investing activities?
The current annual CFI of EVLO is -$622.00 K
What is the all time high annual CFI for Evelo Biosciences?
Evelo Biosciences all-time high annual cash flow from investing activities is $51.97 M
What is Evelo Biosciences annual CFI year-on-year change?
Over the past year, EVLO annual cash flow from investing activities has changed by +$859.00 K (+58.00%)
What is Evelo Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of EVLO is $513.00 K
What is the all time high quarterly CFI for Evelo Biosciences?
Evelo Biosciences all-time high quarterly cash flow from investing activities is $30.12 M
What is Evelo Biosciences quarterly CFI year-on-year change?
Over the past year, EVLO quarterly cash flow from investing activities has changed by +$522.00 K (+5800.00%)
What is Evelo Biosciences TTM cash flow from investing activities?
The current TTM CFI of EVLO is $273.00 K
What is the all time high TTM CFI for Evelo Biosciences?
Evelo Biosciences all-time high TTM cash flow from investing activities is $81.01 M
What is Evelo Biosciences TTM CFI year-on-year change?
Over the past year, EVLO TTM cash flow from investing activities has changed by +$192.00 K (+237.04%)